PFG Investments, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1973224 WOODBURY, NY

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$2,354,977

-$153,264 QoQ

Shares Held

18,640

+3.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#785

of 2,266 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PFG Investments, LLC holds $74,469,374 across 13 Drug Manufacturers - General names. GILD ranks #8 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	101,254	$25,715,478
2	LLY	ELI LILLY & Co	10,863	$13,029,409
3	ABBV	AbbVie Inc.	38,855	$9,777,472
4	MRK	Merck & Co., Inc.	64,183	$8,247,515
5	PFE	Pfizer Inc	241,469	$5,814,573
6	AMGN	Amgen Inc	10,168	$3,682,036
7	BMY	Bristol Myers Squibb Co	52,772	$3,040,722
8	GILD	Gilead Sciences, Inc. This page	18,640	$2,354,977

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,354,977	18,640	+3.6%	Shares	Sole	2026-07-23
2026-03-31	$2,508,241	17,997	+46.5%	Shares	Sole	2026-04-27
2025-12-31	$1,507,492	12,282	+11.9%	Shares	Sole	2026-01-26
2025-09-30	$1,218,336	10,976	+1.1%	Shares	Sole	2025-10-31
2025-06-30	$1,203,604	10,856	-9.5%	Shares	Sole	2025-07-18
2025-03-31	$1,344,487	11,999	-67.6%	Shares	Sole	2025-04-22
2024-12-31	$3,419,999	37,025	-0.1%	Shares	Sole	2025-01-22
2024-09-30	$3,108,200	37,073	-3.6%	Shares	Sole	2024-10-24
2024-06-30	$2,639,563	38,472	+4.0%	Shares	Sole	2024-08-07
2024-03-31	$2,709,371	36,988	+298.6%	Shares	Sole	2024-04-22
2023-12-31	$751,691	9,279	-42.4%	Shares	Sole	2024-01-17
2023-09-30	$1,207,882	16,118	-4.8%	Shares	Sole	2023-11-06
2023-06-30	$1,304,178	16,922	-5.5%	Shares	Sole	2023-08-03
2023-03-31	$1,485,494	17,904	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.